Anthrax Protective Antigen-directed Antibody Interactions [MoA] - N0000192702

Pharmacologic Class Information

Pharmacologic Code N0000192702
Pharmacologic Name Anthrax Protective Antigen-directed Antibody Interactions
Pharmacologic Uses
  • monoclonal antibody directed against the protective antigen of Bacillus anthracis
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Anthrax Protective Antigen-directed Antibody Interactions

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Anthrax Protective Antigen-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
69604-204Anthim Non-Proprietary Name: ObiltoxaximabSolutionIntravenousElusys Therapeutics, Inc.ACTIVE
71655-103Raxibacumab Non-Proprietary Name: RaxibacumabInjectionIntravenousEmergent Manufacturing Operations Baltimore LlcACTIVE